Resultados de la búsqueda 291-300 of 23173 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. ... The study will be performed in two phases: Phase I will be ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  5. Radiología - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) for future study after treatment with SONALA-001 in combination with MRgFUS in subjects with progressive or rGBM. Improvements In ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

  8. Oncología (médica) - Ensayos clínicos

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...